Global Cord Blood Banking Market: Focus on China

Umbilical cord carries rich nutrient blood and gases to the fetus through arteries and veins it encloses. Blood contained in the umbilical cord is rich in stem cells. In the adult body, there are few active sites of blood cell production. Throughout an individual’s life, they are responsible for producing the blood cells. Blood diseases are treated with chemotherapy, marrow transplants or transfusions but now scientists are able to manipulate hematopoietic stem cells found in umbilical cord blood to form a specific type of cell externally. The stem cells help in treating diseases like leukemia, lymphoma and inherited diseases like sickle cell anemia once it is transplanted.

This report presents an overview of the US, European and Chinese cord blood banking market. China is the largest market for cord blood banking. In China, China Cord Banking Corp. is the largest provider of cord blood storage services. The penetration rate and the number of new subscribers of this company in Beijing and urban and rural segment of Guangdong are also discussed. The number of participating cord blood banks, the number of cord blood units stored and the geographical distribution of cord blood units of Bone Marrow Donors Worldwide are also discussed.

The present report provides a basic understanding of market dynamics in China. This report delves into factors which drive the Chinese cord blood banking market like increase in the number of newborns, increase in per capita heath expenditure, and increase in awareness about cord blood banking. Key issues like entry barriers in cord blood banking, collection and storage problem have been discussed.

The competition prevailing in the global cord blood banking market has also been highlighted including price comparison. The report also profiles the major cord blood banks in China, along with a discussion of their business strategies.